Pegassist
Where Patients Matter
Type a Question Go
Brought to you by the makers of PEGASYSŪ (Peginterferon alfa-2a)
Healthcare Professionals
Patient Education Materials
24-7 Nurse Support
Support Specifically Designed for Your Use During Treatment with PEGASYS
Already a Member? Login Now
Forgot
Password?
Not a member? Sign up is simple
Quick Quote
"Be not afraid of growing slowly, be afraid only of standing still." —Chinese Proverb
Learning About Hepatitis C
What Is Hepatitis? "Hepatitis" is a Latin word meaning "inflamed liver." Liver inflammation is often caused by a virus. Other causes may include alcohol (alcoholic hepatitis), certain medications (drug-induced hepatitis), toxins (toxic hepatitis), or autoimmune disorders.

While many viruses can affect the liver as part of their spread through the body (for example, the infectious mononucleosis virus), some viruses primarily infect the liver. There are 5 well-characterized types of viral hepatitis: A, B, C, D, and E. All viral forms of hepatitis can be spread from one person to another, although the mode of transmission may differ for each. Hepatitis C affects more than 180 million people worldwide. Chronic hepatitis C is now the most common reason for liver transplantation and the leading cause in the United States for developing liver cancer.

Hepatitis A (which is spread by contaminated food and water or in conditions of poor hygiene) and hepatitis B (transmitted through blood-to-blood contact) are also very widespread. A single person may be infected with more than one type of hepatitis. Because of the risk of additional liver damage, you should ask your doctor or nurse about getting vaccinations against hepatitis A and hepatitis B.

When you have hepatitis C, you must avoid alcohol and talk to your doctor or nurse about all medications or other drugs you are taking. You are at risk of liver inflammation, and potentially increased liver damage, caused by drinking and inhaled or swallowed toxins or medications.

For information about hepatitis C, including its causes, how it develops, and how to prevent its spread, see What Is Hepatitis C?

Find out more about hepatitis A.

Find out more about hepatitis B.

Learn more about other forms of hepatitis.

About Hepatitis A

Hepatitis A is very common in the U.S. population: 1 out of 3 Americans has been infected at some point. Most people who are exposed to hepatitis A recover completely without treatment and, once the infection has subsided, develop lifelong immunity to the disease.

Because it is so common, people without a medical background may think of hepatitis A first when they hear "hepatitis." You may want to be proactive and explain the differences between the A and C forms of the condition to those close to you.

Hepatitis A is transmitted primarily by the fecal-to-oral route through contaminated food or water, or because of poor hygiene. Hepatitis A can also be contracted by eating shellfish from contaminated water sources.

People who are infected with hepatitis A generally develop flu-like symptoms, such as low-grade fever, aches, and mild abdominal pain within 10 to 40 days after exposure. For some people, these flu-like symptoms may be followed by jaundice (a yellowing of the eyes and skin). Most people recover from hepatitis A on their own without treatment. However, in fewer than 1% of cases, severe hepatitis A infections may progress to liver failure and to a need for liver transplantation. Hepatitis A does not lead to the development of chronic hepatitis, cirrhosis (scarring of the liver), or liver cancer.

A vaccine is available to protect against hepatitis A. It is generally recommended for anyone who has hepatitis C, because an additional liver infection may cause more serious problems to develop.

You can reduce the likelihood of contracting hepatitis A by washing your hands with warm water and soap, particularly after using the toilet or changing diapers, and before preparing and eating food. Good hygiene practices are especially important for anyone who works with food.

About Hepatitis B

Hepatitis B is transmitted through blood or blood products, through sexual contact, or from mother to child during childbirth.

Hepatitis B is less common that hepatitis C, but many people don't have a clear understanding of the difference. When you talk about hepatitis C, some people may be thinking of hepatitis B and assume that you have a sexually transmitted disease because hepatitis B is a type of viral hepatitis more easily transmitted sexually. Acquiring hepatitis C through sexual contact is uncommon. You may or may not want to address this issue directly with those close to you—but it is something to keep in mind.

In the United States, an estimated 1.25 million people are chronically infected with hepatitis B. According to the U.S. Centers for Disease Control and Prevention (CDC), about 30% of people who are infected with hepatitis B do not have any symptoms of the disease. Others may experience flu-like symptoms, including low-grade fever, aches, and mild abdominal pain.

Although individuals with healthy immune systems usually recover from hepatitis B on their own after about 6 months, 5% to 10% of those who are infected are at risk of developing the chronic (long-term) form of the disease. Most often those with long-term infection have no symptoms, although some people may suffer from fatigue, malaise, and periods of jaundice. If left untreated, these individuals may be at risk for serious complications of liver damage such as cirrhosis, liver failure, or liver cancer. Severe hepatitis B can be treated with interferon products, lamivudine, other antiviral drugs such as adefovir, or a combination of drugs.

A highly effective vaccine has been developed to help protect against hepatitis B. Currently, the CDC is supporting a universal childhood vaccination program with the goal of eliminating the spread of hepatitis B altogether. In general, the vaccine is recommended for people with hepatitis C.

The risk of hepatitis B transmission can be lowered by carefully cleaning up blood and blood products, practicing safe sex, and not sharing needles, razors, or other personal care items (such as toothbrushes and nail clippers) that might come into contact with blood. To help prevent mother-to-child transmission, all pregnant women should be tested for the hepatitis B virus. Newborns of mothers who are hepatitis-B-positive must be vaccinated against the condition and receive other precautionary treatments at the time of birth.

Other Forms of Hepatitis

Hepatitis D is only found in people with hepatitis B (since the hepatitis D virus needs the hepatitis B virus to reproduce). It is treated in the same way as hepatitis B. Hepatitis D infection is often seen as a "complication" of hepatitis B because it may make the original hepatitis B infection worse but cannot be treated on its own. The highest infection rates are seen in Africa, Southern Italy, Greece, Eastern Europe, and South America.

Hepatitis E, like hepatitis A, is spread primarily in contaminated food and water. Hepatitis E is rare in the United States but has occurred in epidemics in India, Pakistan, China, Northern and Central Africa, and Central America. The infection has been seen in tourists returning from travel to those areas. The body usually clears this virus naturally over the course of several weeks.

Add to My Folder
Type How It Is Spread Who Is at Risk Prevention Treatment
Hepatitis A Food or water contaminated by feces from an infected person; eating shellfish from contaminated water sources Anyone exposed to contaminated food or water; very common (1 of 3 people in United States has been infected) Effective vaccine available; sanitary food handling practices; washing hands after toilet use or changing diapers Symptoms may be treated, but virus is usually cleared by the body without treatment
Hepatitis B Unsterile needles; blood or blood products; sexual contact; or from mother to child during childbirth Injection drug users; people with multiple sex partners; people exposed to blood or blood products (for medical procedures or through their work) Effective vaccine available; practicing safe sex; not sharing needles or personal items that may be contaminated with blood Interferon-based products, lamivudine, other antiviral drugs, or combination therapies
Hepatitis C Unsterile needles; blood or blood products; or from mother to child during childbirth. (Sexual transmission is uncommon) Injection drug users; people exposed to blood or blood products (for medical procedures or through their work) Not sharing needles or personal items that may be contaminated with blood Interferon-based products, ribavirin
Hepatitis D Blood-to-blood contact. Occurs only in people already infected with hepatitis B Anyone infected with hepatitis B. Injection drug users who have hepatitis B have the highest risk Immunization against hepatitis B for those not already infected; avoiding exposure to infected blood Same as for hepatitis B
Hepatitis E Food or water contaminated by feces from an infected person. (Uncommon in the United States) International travelers; people who live in areas where hepatitis E is common; sexual partners of infected people No vaccine available; reduce contact with food or water that may be contaminated Usually resolves without treatment in several weeks; however 1% to 2% of cases are fatal

Back to Top

Safety Information

What is PEGASYS?

PEGASYS is a medicine used to treat some adults who have hepatitis C and signs of liver damage. PEGASYS works to reduce the amount of virus in your blood, helping your body fight the virus.

PEGASYS® (Peginterferon alfa-2a), like other alpha interferons, can cause fatal or make life-threatening problems worse (like mental, immune system, heart, liver, lung, intestinal and infections). Your doctor should monitor you during regular visits. If you show signs or symptoms of these conditions, your doctor may stop your medication. In most patients, these conditions get better after you stop taking PEGASYS (see medication guide for more information and warnings).

What is COPEGUS?

COPEGUS is a medicine that works by slowing down the growth of the virus. COPEGUS should be taken with PEGASYS to fight the virus. Do not take COPEGUS by itself.

COPEGUS® (Ribavirin, USP) can be extremely harmful and cause birth defects in an unborn baby. Female patients and the female partners of male patients should avoid getting pregnant. Ribavirin is known to cause anemia (low red blood cells), which can make heart disease worse. Also, ribavirin can harm your DNA and possibly cause cancer (see medication guide for more information and warnings).

Who should not take PEGASYS and COPEGUS?

Do not take PEGASYS alone or with COPEGUS if:

  • You are pregnant or your partner is pregnant
  • You or your partner plans to get pregnant during therapy or within 6 months after treatment ends
  • You are breastfeeding
  • You have hepatitis caused by your immune system (autoimmune hepatitis)
  • You have unstable or severe liver disease before or during treatment
  • You are allergic to alpha interferons or any of the ingredients in PEGASYS and COPEGUS
  • You have abnormal red blood cells (caused by conditions like sickle-cell anemia or thalassemia major)

What if I am pregnant or thinking about having a baby?

If you are a woman who could get pregnant, you must take pregnancy tests before, during and for 6 months after treatment ends to make sure you are not pregnant.

During treatment and for 6 months after treatment, female and male patients must:

  • Use two forms of birth control (one being a condom with spermicide)
  • Tell your doctor right away if you or your partner becomes pregnant. You or
    your doctor should also call the Ribavirin Pregnancy Registry at 1-800-593-2214

What medication should I avoid when I am taking PEGASYS and COPEGUS?

You should not take didanosine with COPEGUS. Talk to your doctor about all medications that you are taking.

What are the possible side effects?

The most common side effects of PEGASYS and COPEGUS are:

  • Flu-like symptoms (including fever, chills, muscle aches, joint pain, headaches)
  • Tiredness
  • Upset stomach (like nausea, taste changes, diarrhea)
  • Blood sugar problems (may lead to diabetes)
  • Skin problems (like rash, dry or itchy skin, redness and swelling at injection site)
  • Hair loss (temporary)
  • Trouble sleeping

The most serious side effects of PEGASYS and COPEGUS are:

  • Risks to pregnancies
  • Mental health problems (such as irritability, depression, anxiety, aggressiveness, trouble with drug addiction or overdose, thoughts about suicide, suicide attempts, suicide and thoughts about homicide)
  • Blood problems (like a drop in blood cells leading to increased risk for infections, bleeding and/or heart or circulatory problems)
  • Infections (which sometimes cause death)
  • Lung problems (like trouble breathing, pneumonia)
  • Eye problems (like blurred vision, loss of vision)
  • Autoimmune problems (such as psoriasis, thyroid problems)
  • Heart problems (including chest pain and, rarely, a heart attack)
  • Liver problems (rarely, liver function worsens). Patients with both the hepatitis C virus and HIV can have an increased chance of having liver failure during PEGASYS treatment. Change in a blood test that measures liver inflammation occurs more often in patients with hepatitis B. If you have a rise in this blood test you may need to be watched more closely with additional blood tests.

Tell your doctor immediately if you think you or your partner may be pregnant or if any of these symptoms occur.

This information does not take the place of talking to your healthcare professional about your medical condition or your treatment.

Please see the medication guides and complete product information for PEGASYS and COPEGUS.

 

THIS SITE INTENDED FOR U.S. AUDIENCES ONLY

For more information about PEGASYS, contact your physician or other healthcare professional.

Roche
Copyright © 2003-2008 Hoffmann-La Roche Inc. All rights reserved. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and PRIVACY Statement. Because Pegassist.com offers some unique features and options, Roche provides additional protection tailored to those items. Click here to read Additional Details about your Privacy.
   
eHealthcare Leadership Awards 2004 Winner, Gold Award: Best Care/Disease Management Site Brought to you by the makers of PEGASYS® (Peginterferon alfa-2a)
Gold Award:
Best Care/Disease
Management Site